{
  "docId": "019de074-d961-7389-a20b-cd17e719b042",
  "docSlug": "eb72a4aa6f7d8bed68bc577a406605bf",
  "documentTitle": "BioAtla | Investor Presentation Deck | 44 slides",
  "authorId": "bioatla",
  "authorName": "BioAtla",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-05-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 36,
  "pageCount": 44,
  "prevPage": 35,
  "nextPage": 37,
  "slideType": "comparison_table",
  "function": "compare_peers",
  "density": "overcrowded",
  "nDataPoints": 12,
  "notes": "The slide uses a combination of a summary table for clinical data and a dot plot for NHP toxicity data.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de074-d961-7389-a20b-cd17e719b042/36",
  "deckHref": "/decks/019de074-d961-7389-a20b-cd17e719b042",
  "deckJsonHref": "/decks/019de074-d961-7389-a20b-cd17e719b042.json",
  "deckAnchorHref": "/decks/019de074-d961-7389-a20b-cd17e719b042#slide-36",
  "components": [
    {
      "bbox": {
        "h": 0.3,
        "w": 0.5,
        "x": 0.47,
        "y": 0.54
      },
      "kind": "chart",
      "text": "NHP study toxicity dot plot comparing Vehicle, Nivo+Ipi, and Nivo+BA3071",
      "attrs": null,
      "subkind": "dot",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "437395f0-19b6-4992-9344-9f0bf7cd7b69",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.38,
        "x": 0.05,
        "y": 0.64
      },
      "kind": "paragraph",
      "text": "In NHP study, BA3071 achieved similar exposure levels to Ipi analog with significantly less toxicity in combination with nivo.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5589d6c0-f49d-4def-b3d9-db674850edce",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.4,
        "x": 0.035,
        "y": 0.25
      },
      "kind": "paragraph",
      "text": "Research demonstrates challenges and opportunity in combining two Immune Checkpoint Inhibitors. Improves efficacy, but increases adverse events. Greater % of patients discontinue therapy relative to monotherapy.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f51b8621-a985-4513-b189-26699229cdb8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.55,
        "x": 0.105,
        "y": 0.885
      },
      "kind": "source-note",
      "text": "Larkin et al., New Eng. J. Med., 2015; Chang et al., PNAS 2021. Nivo: 20mg/kg QW; Ipi or CAB-CTLA: 15mg/kg QW.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "85d7bd4f-3153-42d4-bec6-10ed6588ee28",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.18,
        "w": 0.5,
        "x": 0.467,
        "y": 0.242
      },
      "kind": "table",
      "text": "Clinical Endpoint, Nivolumab (PD-1), Nivolumab (PD-1) + Ipilimumab (CTLA4), Progression Free Survival, 6.9 months, 11.5 months, Grade 3 or 4 Adverse Events, 16.3%, 55.0%, Discontinued Treatment, 7.7%, 36.4%",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3eef7023-69a8-4703-9ee4-53c47fdc6c08",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.5,
        "x": 0.03,
        "y": 0.14
      },
      "kind": "title",
      "text": "Best-in-class and potential for disruption of the I/O Market",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3f549fac-8ca7-483f-97f8-2b89a44f32d3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.3,
        "x": 0.03,
        "y": 0.08
      },
      "kind": "title",
      "text": "BA3071 (CAB-CTLA-4)",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1d08f624-99c5-4b33-8c60-0cdd3c426164",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}